Cash Flow Fusen Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-23.00
-93.00
12.00
-11.00
31.00
60.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
76.00
163.00
-118.00
68.00
-36.00
49.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
135.00
145.00
-44.00
152.00
58.00
175.00
Cash Flow from Investing Activities
-6.00
-177.00
-178.00
-15.00
-341.00
-80.00
Cash Flow from Financing Activities
-62.00
17.00
97.00
-60.00
24.00
-130.00
Net Cash Inflow / Outflow
68.00
-14.00
-125.00
78.00
-260.00
-38.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
1.00
-1.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Fusen Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-23.9202474646582
69.7450420731279
-92.00
-134.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
76.8167903482836
138.959199794303
-62.00
-44.72%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
135.749790313351
295.83656661883
-160.00
-54.11%
Cash Flow from Investing Activities
-6.54943663579394
-7.689607627299
1.00
14.83%
Cash Flow from Financing Activities
-62.5813365841784
-234.111614034335
172.00
73.27%
Net Cash Inflow / Outflow
68.0939688775615
54.024435595622
14.00
26.04%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.47495178418277
-0.010909361574137
1.00
13620.06%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -6.39% vs 427.91% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
135.75
145.02
-6.39%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
